The Defense Contract That Delivered Zero — And Kept Getting More Chances

The Army poured nearly half a billion dollars into a Texas ammo plant that, two years later, has not delivered a single usable artillery shell part — and the story behind that failure says a lot about how Washington treats your money and our warfighters.

Story Snapshot

A $469–$500 million Mesquite, Texas artillery plant has produced zero qualifying 155mm shell parts in two years.
The Army’s goal of 100,000 shells per month is stalled at roughly one‑third of that after the Mesquite flop.
Pentagon watchdogs, “show cause” letters, and an eight‑month work stoppage still did not kill the contract.
General Dynamics now promises a $200 million reboot, raising hard questions about accountability and priorities.

A half-billion-dollar plant that never delivered a single part

The Mesquite Universal Artillery Projectile Lines facility opened with fanfare in 2024 as a key piece of the Army’s push to boost 155mm shell output to 100,000 rounds per month. The Army spent about $469 million on the contractor‑operated plant, expecting 30,000 projectile metal parts each month by October 2025. Yet by March 2026, a Pentagon inspector general report found the factory had not produced one metal projectile part that met Army contract specifications.

Representative Rob Wittman told Congress that, nearly two years after opening, the facility “has yet to produce a single projectile for 155, or any other artillery for that matter.” A separate watchdog summary said the Mesquite plant “has not delivered a single qualifying part in two years of operation,” confirming that none of the output counted toward the Army’s needs. For a government‑owned plant built to feed a shooting war’s ammo demand, zero acceptable parts after two years is not a glitch. It is a failure.

Failed lines, stop-work orders, and a stalled shell surge

The plan was simple on paper: three Universal Artillery Projectile Lines would turn steel into 30,000 shell bodies per month, helping the Army hit its 100,000‑round target. In practice, the lines never became fully operational. The Army’s acquisition chief told lawmakers the plant still was not producing needed projectiles and that the service remained far short of its goal. By March 2026, the inspector general reported the Army was only producing about 36,000 rounds per month overall, largely because Mesquite never delivered its share.

Things got so bad that the Army issued a “show cause” letter, threatening to terminate General Dynamics Ordnance and Tactical Systems’ management of the plant if it could not meet key completion dates for the three lines. The service also sent a formal “cure notice” over poor performance at the Mesquite metal parts facility, a strong signal that patience was wearing thin. On top of that, the Army ordered an eight‑month stop‑work at the plant starting in August 2025, freezing activity until April 2026. Yet even with all that pressure, no qualifying shell parts came off the line.

Confusing numbers and a foggy public picture

Some coverage has added confusion by mixing up different types of production. One outlet claimed the Mesquite plant was “currently only producing around 56,000 shells” per month, blaming automation issues and explosive shortages. But Pentagon watchdogs and Army testimony draw a much sharper line: the Mesquite facility has not produced any projectile metal parts that meet contract specifications. That gap matters. A shell that fails standards is not a shell the Army can send to the field.

Several reports also note that other plants are still producing 155mm shells, which lets officials say the Army is “hitting stride” elsewhere. That broader surge narrative risks hiding the core problem. The Mesquite plant was supposed to provide 30,000 additional projectile parts each month. Without them, the inspector general warned the Army will only reach about 71,000 rounds per month, or 71 percent of its stated goal. American conservative values and basic common sense say you judge the project that took the money and missed the mark, not hide it under better news from somewhere else.

Why Repkon’s failed technology matters for accountability

The technical heart of the mess sits in the equipment. The Army and General Dynamics relied on advanced manufacturing gear tied to a Turkish partner, Repkon, to run the automated lines. The inspector general and later media reports say that this equipment never met required standards, even after rework, and could not produce acceptable M795 shell parts. The Army’s response was to halt work and demand fixes, but it still kept the main contract in place and moved slowly on penalties.

A Pentagon watchdog report found that in the roughly two years since it was built, an ammunition plant in Mesquite, Texas, has not produced any parts for 155mm artillery rounds, hindering the Army's goal to help backfill stocks of ammunition provided to Ukraine after Russia…

— Beefeater (@Beefeater_Fella) July 15, 2026

General Dynamics now promises to invest about $200 million of its own money to rip out the failed Repkon systems and replace them with hardware and management from a new firm, Deterrence Defense. Supporters argue that putting private capital at risk shows real accountability and a serious reboot effort. Skeptics look at the same move and see a “sunk cost” defense, where the contractor spends more to keep the deal alive instead of facing a clean loss. When a half‑billion taxpayer project delivers zero usable parts, the burden of proof should rest firmly on the contractor.

A familiar pattern in defense spending and a test for reform

This is not an isolated fiasco. Studies of Defense Department acquisition show that a large share of major programs suffer big delays and cost overruns when leaders chase ambitious production goals with immature technology. The Mesquite plant fits that pattern: aggressive shell targets, advanced automation, foreign‑linked equipment, and weak oversight until the failure became impossible to hide. The inspector general even described a lack of a clear plan to replace Mesquite’s missing 30,000 parts, leaving the broader ammo surge exposed.

Recent policy from the White House stresses “prioritizing the warfighter” and calling out underperforming contractors who do not invest their own capital in critical weapons programs. On paper, that is exactly the kind of standard Mesquite should meet. In reality, watchdogs had to flag that the plant produced nothing usable, Congress had to drag officials in to explain, and only then did General Dynamics step up with its own money. If reform is serious, the Mesquite case should be a test: full transparency on what went wrong, hard milestones for the reboot, and a real willingness to cut ties if the plant still fails to deliver.